Differential Effects of Isosorbide-5-Mononitrate on Epicardial Coronary Arteries and Relevant Hemodynamic Parameters: Special Aspects of Nitrate Action

  • E. Bassenge
  • D. J. Stewart
Conference paper
Part of the International Boehringer Mannheim Symposia book series (BOEHRINGER)


Isosorbide-5-mononitrate (IS-5-MN) and other nitrates are potent antianginal agents. It is becoming clear that they owe their therapeutic efficacy to a very special pattern of vascular and hemodynamic response, possibly unique to this class of vasodilators. In the present review, the vasodilator spectrum of IS-5-MN will be highlighted, with special attention to the relevance of these effects for the treatment of angina pectoris. In addition, evidence will be discussed pointing to novel mechanisms, which may contribute to the unequaled performance of these agents in the treatment of ischemic heart disease.


Ventricular Filling Pressure Nitrate Action Coronary Arteriole Small Coronary Artery Coronary Artery Diameter 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Azuma H, Ishikawa M, Sekizaki S (1986) Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 88: 411–415PubMedGoogle Scholar
  2. 2.
    Bassenge E, Pohl U (1985) Effect of molsidomine on cardiac preload, coronary diameter and coronary resistance. Am Heart J 109: 627–630PubMedCrossRefGoogle Scholar
  3. 3.
    Bassenge E, Strein K (1986) Dose-dependent effects ofisosorbide-5-mononitrate on the venous, arterial and coronary arterial system of conscious dogs. Naunyn-Schmiedebergs Arch Pharmacol 334: 100–104PubMedCrossRefGoogle Scholar
  4. 4.
    Busse R, Lückhoff A, Bassenge E: (1987) Endothelium-derived relaxant factor inhibits platelet activation. Naunyn Schmiedeberg’s Arch Pharmacol; in pressGoogle Scholar
  5. 4a.
    Cohen MY, Kirk ED (1973) Differential response of large and small coronary arteries to nitroglycerin and angiotensin: autoregulation and tachyphylaxis. Circ Res 33: 445–453PubMedGoogle Scholar
  6. 5.
    Feldmann RL, Pepine CJ Conti R (1981) Magnitude of dilation of large and small coronary arteries by nitroglycerin. Circulation 64: 324–333CrossRefGoogle Scholar
  7. 6.
    Förstermann, U, Mülsch A, Böhme E, Busse R (1986) Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ Res 58: 531–538PubMedGoogle Scholar
  8. 7.
    Holtz J, Förstermann U, Pohl U, Giesler M, Bassenge E (1984) Flow-dependent, endotheliummediated dilation of epicardial arteries in concious dogs: effects of cyclooxygenase inhibition. J Cardiovasc Dis. 6: 1161–1169Google Scholar
  9. 8.
    Kinsella D, Troup W, McGregor M (1962) Studies with a new coronary vasodilator drug: persantin. Am Heart J. 63: 146–151PubMedCrossRefGoogle Scholar
  10. 9.
    McGregor M (1982) The nitrates and myocardial ischemia. Circulation 66: 689–692.PubMedCrossRefGoogle Scholar
  11. 10.
    Müller-Beckman B, Gross, GJ (1986) Effect of isosorbide-5-mononitrate on true coronary collateral blood flow in dogs. In: 2nd International Symposium on Mononitrates, Berlin 1986Google Scholar
  12. 11.
    Müller O, Rorvik K (1973) Hemodynamic consequences of coronary heart disease. Br Heart J 20: 302–307CrossRefGoogle Scholar
  13. 12.
    Murad F (1987) Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 78: 1–5.CrossRefGoogle Scholar
  14. 13.
    Murray JJ, Fridovich I, Makhoul RG, Hagen P-O (1986) Stabilization and partial characterization of endothelium-derived relaxing factor from cultured bovine aortic endothelial cells. Biochem Biophy Res Com 141: 689–696CrossRefGoogle Scholar
  15. 14.
    Pohl U, Holtz J, Busse R, Bassenge E (1986) Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 8: 37–44PubMedGoogle Scholar
  16. 15.
    Rubanyi GM, Romeo CJ, Vanhoutte PM: Flow induced release of endothelium-derived relaxing factor. Am J Physiol 250: H1145–1149Google Scholar
  17. 16.
    Stewart DJ, Elsner D, Sommer O, Holtz J, Bassenge E (1986) Altered spectrum of nitroglycerin action in long-term treatment: nitroglycerin-specific venous tolerance with maintenance of arterial vasodepressor potency. Circulation 74: 573–582PubMedCrossRefGoogle Scholar
  18. 17.
    Stewart DJ, Holtz J, Bassenge E (1987) Long-term nitroglycerin treatment: effect on direct and endothelium-mediated large coronary artery dilation in conscious dogs. Circulation (in press)Google Scholar
  19. 18.
    Strein K, Bossert F, Bartsch W, Hooper R (1986) Pharmacodynamics of organic nitrates- in vitro and in vivo studies. 2nd International Symposium of mononitrate, Berlin, pp 6–8Google Scholar
  20. 19.
    Tauchert M, Behrenbeck DW, Hötzel J, Hilger HH (1976) Ein neuerpharmakologischer Test zur Diagnose der Koronarinsuffizienz. DMW 2: 35–37CrossRefGoogle Scholar
  21. 20.
    Winbury MM, Howe BB, Hefner MA (1969) Effect of nitrates and other coronary dilators on large and small coronary vessels: an hypothesis for the mechanism of action of nitrates. J Pharmacol Exp Ther 168: 70–95PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • E. Bassenge
  • D. J. Stewart

There are no affiliations available

Personalised recommendations